PTPA and cancer: Essentially, these studies were able to demonstrate that the PP2A inhibitor combined with a DNA disrupting agent will result in DNA-damaged cancer cells progressing through the cell cycle, ultimately leading to cell death via mitotic catastrophe [118, 128, 129].